A -Acting Protein Effect Causes Severe Eye Malformation in the Mouse

English version České info

Mp is an irradiation-induced mouse mutation associated with microphthalmia, micropinna and hind limb syndactyly. We show that Mp is caused by a 660 kb balanced inversion on chromosome 18 producing reciprocal 3-prime gene fusion events involving Fbn2 and Isoc1. The Isoc1-Fbn2 fusion gene (Isoc1^Mp) mRNA has a frameshift and early stop codon resulting in nonsense mediated decay. Homozygous deletions of Isoc1 do not support a significant developmental role for this gene. The Fbn2-Isoc1 fusion gene (Fbn2^Mp) predicted protein consists of the N-terminal Fibrillin-2 (amino acids 1–2646, exons 1–62) lacking the C-terminal furin-cleavage site with a short out-of-frame extension encoded by the final exon of Isoc1. The Mp limb phenotype is consistent with that reported in Fbn2 null embryos. However, severe eye malformations, a defining feature of Mp, are not seen in Fbn2 null animals. Fibrillin-2^Mp forms large fibrillar structures within the rough endoplasmic reticulum (rER) associated with an unfolded protein response and quantitative mass spectrometry shows a generalised defect in protein secretion in conditioned media from mutant cells. In the embryonic eye Fbn2 is expressed within the peripheral ciliary margin (CM). Mp embryos show reduced canonical Wnt-signalling in the CM – known to be essential for ciliary body development - and show subsequent aplasia of CM-derived structures. We propose that the Mp “worse-than-null” eye phenotype plausibly results from a failure in normal trafficking of proteins that are co-expressed with Fbn2 within the CM. The prediction of similar trans-acting protein effects will be an important challenge in the medical interpretation of human mutations from whole exome sequencing.

Vyšlo v časopise: A -Acting Protein Effect Causes Severe Eye Malformation in the Mouse. PLoS Genet 9(12): e32767. doi:10.1371/journal.pgen.1003998
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1003998

Souhrn

Zdroje

1. WormanHJ, FongLG, MuchirA, YoungSG (2009) Laminopathies and the long strange trip from basic cell biology to therapy. J Clin Invest 119: 1825–1836.

2. RobertsonSP (2005) Filamin A: phenotypic diversity. Curr Opin Genet Dev 15: 301–307.

3. WilkieAO (2005) Bad bones, absent smell, selfish testes: the pleiotropic consequences of human FGF receptor mutations. Cytokine Growth Factor Rev 16: 187–203.

4. Roussel BDKA, MirandaE, CrowtherDC, LomasDA, MarciniakSJ (2013) Endoplasmic reticulum dysfunction in neurological disease. Lancet Neurol 12: 105–118.

5. XiaK, MaH, XiongH, PanQ, HuangL, et al. (2010) Trafficking abnormality and ER stress underlie functional deficiency of hearing impairment-associated connexin-31 mutants. Protein Cell 1: 935–943.

6. TsangKY, ChanD, CheslettD, ChanWC, SoCL, et al. (2007) Surviving endoplasmic reticulum stress is coupled to altered chondrocyte differentiation and function. PLoS Biol 5: e44.

7. VijN, FangS, ZeitlinPL (2006) Selective inhibition of endoplasmic reticulum-associated degradation rescues DeltaF508-cystic fibrosis transmembrane regulator and suppresses interleukin-8 levels: therapeutic implications. J Biol Chem 281: 17369–17378.

8. MorrisonD, FitzpatrickD, HansonI, WilliamsonK, van HeyningenV, et al. (2002) National study of microphthalmia, anophthalmia, and coloboma (MAC) in Scotland: investigation of genetic aetiology. Journal of Medical Genetics 39: 16–22.

9. StollC, AlembikY, DottB, RothMP (1997) Congenital eye malformations in 212,479 consecutive births. Ann Genet 40: 122–128.

10. FitzpatrickDR, van HeyningenV (2005) Developmental eye disorders. Curr Opin Genet Dev 15: 348–353.

11. FantesJ, RaggeNK, LynchSA, McGillNI, CollinJR, et al. (2003) Mutations in SOX2 cause anophthalmia. Nat Genet 33: 461–463.

12. RaggeNK, LorenzB, SchneiderA, BushbyK, de SanctisL, et al. (2005) SOX2 anophthalmia syndrome. Am J Med Genet A 135: 1–7 discussion 8.

13. RaggeNK, BrownAG, PoloschekCM, LorenzB, HendersonRA, et al. (2005) Heterozygous mutations of OTX2 cause severe ocular malformations. Am J Hum Genet 76: 1008–1022.

14. PasuttoF, StichtH, HammersenG, Gillessen-KaesbachG, FitzpatrickDR, et al. (2007) Mutations in STRA6 cause a broad spectrum of malformations including anophthalmia, congenital heart defects, diaphragmatic hernia, alveolar capillary dysplasia, lung hypoplasia, and mental retardation. Am J Hum Genet 80: 550–560.

15. ReisLM, TylerRC, SchneiderA, BardakjianT, StolerJM, et al. (2010) FOXE3 plays a significant role in autosomal recessive microphthalmia. Am J Med Genet A 152A: 582–590.

16. AbouzeidH, BoissetG, FavezT, YoussefM, MarzoukI, et al. (2011) Mutations in the SPARC-related modular calcium-binding protein 1 gene, SMOC1, cause waardenburg anophthalmia syndrome. Am J Hum Genet 88: 92–98.

17. OkadaI, HamanoueH, TeradaK, TohmaT, MegarbaneA, et al. (2011) SMOC1 is essential for ocular and limb development in humans and mice. Am J Hum Genet 88: 30–41.

18. RaingerJ, van BeusekomE, RamsayJK, McKieL, Al-GazaliL, et al. (2011) Loss of the BMP antagonist, SMOC-1, causes Ophthalmo-acromelic (Waardenburg Anophthalmia) syndrome in humans and mice. PLoS Genet 7: e1002114.

19. GlaserT, JepealL, EdwardsJG, YoungSR, FavorJ, et al. (1994) PAX6 gene dosage effect in a family with congenital cataracts, aniridia, anophthalmia and central nervous system defects. Nat Genet 7: 463–471.

20. Gerth-Kahlert CWK, AnsariM, RaingerJ, HignstV, ZimmermannT, et al. (2013) Clinical and Mutation Analysis of 51 Probands with Anophthalmia and/or Severe Microphthalmia from a Single Centre. Molecular Genetics & Genomic Medicine 1: 15–31.

21. FurutaY, HoganBL (1998) BMP4 is essential for lens induction in the mouse embryo. Genes Dev 12: 3764–3775.

22. KamachiY, UchikawaM, CollignonJ, Lovell-BadgeR, KondohH (1998) Involvement of Sox1, 2 and 3 in the early and subsequent molecular events of lens induction. Development 125: 2521–2532.

23. MatsushimaD, HeavnerW, PevnyLH (2011) Combinatorial regulation of optic cup progenitor cell fate by SOX2 and PAX6. Development 138: 443–454.

24. BeebeDC (1986) Development of the ciliary body: a brief review. Trans Ophthalmol Soc U K 105 (Pt 2) 123–130.

25. AgathocleousM, IordanovaI, WillardsenMI, XueXY, VetterML, et al. (2009) A directional Wnt/beta-catenin-Sox2-proneural pathway regulates the transition from proliferation to differentiation in the Xenopus retina. Development 136: 3289–3299.

26. Van RaayTJ, MooreKB, IordanovaI, SteeleM, JamrichM, et al. (2005) Frizzled 5 signaling governs the neural potential of progenitors in the developing Xenopus retina. Neuron 46: 23–36.

27. ChoSH, CepkoCL (2006) Wnt2b/beta-catenin-mediated canonical Wnt signaling determines the peripheral fates of the chick eye. Development 133: 3167–3177.

28. TaranovaOV, MagnessST, FaganBM, WuY, SurzenkoN, et al. (2006) SOX2 is a dose-dependent regulator of retinal neural progenitor competence. Genes Dev 20: 1187–1202.

29. PhippsE (1964) Mp. Mouse News Letter 31: 41.

30. Arteaga-SolisE, GayraudB, LeeSY, ShumL, SakaiL, et al. (2001) Regulation of limb patterning by extracellular microfibrils. J Cell Biol 154: 275–281.

31. ChaudhrySS, GazzardJ, BaldockC, DixonJ, RockMJ, et al. (2001) Mutation of the gene encoding fibrillin-2 results in syndactyly in mice. Hum Mol Genet 10: 835–843.

32. MillerG, NeilanM, ChiaR, GheryaniN, HoltN, et al. (2010) ENU mutagenesis reveals a novel phenotype of reduced limb strength in mice lacking fibrillin 2. PLoS One 5: e9137.

33. MarettoS, CordenonsiM, DupontS, BraghettaP, BroccoliV, et al. (2003) Mapping Wnt/beta-catenin signaling during mouse development and in colorectal tumors. Proc Natl Acad Sci U S A 100: 3299–3304.

34. JohnsonKR, CookSA, ZhengQY (1998) The original shaker-with-syndactylism mutation (sy) is a contiguous gene deletion syndrome. Mamm Genome 9: 889–892.

35. LeeB, GodfreyM, VitaleE, HoriH, MatteiMG, et al. (1991) Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. Nature 352: 330–334.

36. PutnamEA, ZhangH, RamirezF, MilewiczDM (1995) Fibrillin-2 (FBN2) mutations result in the Marfan-like disorder, congenital contractural arachnodactyly. Nat Genet 11: 456–458.

37. WangM, ClericuzioCL, GodfreyM (1996) Familial occurrence of typical and severe lethal congenital contractural arachnodactyly caused by missplicing of exon 34 of fibrillin-2. Am J Hum Genet 59: 1027–1034.

38. Piha-GossackA, SossinW, ReinhardtDP (2012) The evolution of extracellular fibrillins and their functional domains. PLoS One 7: e33560.

39. ChangYF, ImamJS, WilkinsonMF (2007) The nonsense-mediated decay RNA surveillance pathway. Annu Rev Biochem 76: 51–74.

40. NagyE, MaquatLE (1998) A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance. Trends Biochem Sci 23: 198–199.

41. DixonMJ, GazzardJ, ChaudhrySS, SampsonN, SchulteBA, et al. (1999) Mutation of the Na-K-Cl co-transporter gene Slc12a2 results in deafness in mice. Hum Mol Genet 8: 1579–1584.

42. ShiY, TuY, De MariaA, MechamRP, BassnettS (2013) Development, composition, and structural arrangements of the ciliary zonule of the mouse. Invest Ophthalmol Vis Sci 54: 2504–2515.

43. KeeneDR, JordanCD, ReinhardtDP, RidgwayCC, OnoRN, et al. (1997) Fibrillin-1 in human cartilage: developmental expression and formation of special banded fibers. J Histochem Cytochem 45: 1069–1082.

44. YoshidaH, MatsuiT, YamamotoA, OkadaT, MoriK (2001) XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107: 881–891.

45. ZhangH, HuW, RamirezF (1995) Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. J Cell Biol 129: 1165–1176.

46. QuondamatteoF, ReinhardtDP, CharbonneauNL, PophalG, SakaiLY, et al. (2002) Fibrillin-1 and fibrillin-2 in human embryonic and early fetal development. Matrix Biol 21: 637–646.

47. Hilhorst-HofsteeY, HamelBC, VerheijJB, RijlaarsdamME, ManciniGM, et al. (2011) The clinical spectrum of complete FBN1 allele deletions. Eur J Hum Genet 19: 247–252.

48. FaivreL, Collod-BeroudG, CallewaertB, ChildA, BinquetC, et al. (2009) Clinical and mutation-type analysis from an international series of 198 probands with a pathogenic FBN1 exons 24–32 mutation. Eur J Hum Genet 17: 491–501.

49. ParkES, PutnamEA, ChitayatD, ChildA, MilewiczDM (1998) Clustering of FBN2 mutations in patients with congenital contractural arachnodactyly indicates an important role of the domains encoded by exons 24 through 34 during human development. Am J Med Genet 78: 350–355.

50. GoldblattJ, HyattJ, EdwardsC, WalpoleI (2011) Further evidence for a marfanoid syndrome with neonatal progeroid features and severe generalized lipodystrophy due to frameshift mutations near the 3′ end of the FBN1 gene. Am J Med Genet A 155A: 717–720.

51. Graul-NeumannLM, KienitzT, RobinsonPN, BaasanjavS, KarowB, et al. (2010) Marfan syndrome with neonatal progeroid syndrome-like lipodystrophy associated with a novel frameshift mutation at the 3′ terminus of the FBN1-gene. Am J Med Genet A 152A: 2749–2755.

52. HornD, RobinsonPN (2011) Progeroid facial features and lipodystrophy associated with a novel splice site mutation in the final intron of the FBN1 gene. Am J Med Genet A 155A: 721–724.

53. RittyTM, BroekelmannT, TisdaleC, MilewiczDM, MechamRP (1999) Processing of the fibrillin-1 carboxyl-terminal domain. J Biol Chem 274: 8933–8940.

54. TsangKY, ChanD, BatemanJF, CheahKS (2010) In vivo cellular adaptation to ER stress: survival strategies with double-edged consequences. J Cell Sci 123: 2145–2154.

55. BishopPN, TakanosuM, Le GoffM, MayneR (2002) The role of the posterior ciliary body in the biosynthesis of vitreous humour. Eye (Lond) 16: 454–460.

56. HalfterW, DongS, SchurerB, RingC, ColeGJ, et al. (2005) Embryonic synthesis of the inner limiting membrane and vitreous body. Invest Ophthalmol Vis Sci 46: 2202–2209.

57. LiuH, MohamedO, DufortD, WallaceVA (2003) Characterization of Wnt signaling components and activation of the Wnt canonical pathway in the murine retina. Dev Dyn 227: 323–334.

58. NakagawaS, TakadaS, TakadaR, TakeichiM (2003) Identification of the laminar-inducing factor: Wnt-signal from the anterior rim induces correct laminar formation of the neural retina in vitro. Dev Biol 260: 414–425.

59. MaddoxBK, KeeneDR, SakaiLY, CharbonneauNL, MorrisNP, et al. (1997) The fate of cartilage oligomeric matrix protein is determined by the cell type in the case of a novel mutation in pseudoachondroplasia. J Biol Chem 272: 30993–30997.

60. MerrittTM, BickR, PoindexterBJ, AlcornJL, HechtJT (2007) Unique matrix structure in the rough endoplasmic reticulum cisternae of pseudoachondroplasia chondrocytes. Am J Pathol 170: 293–300.

61. DinserR, ZauckeF, KreppelF, HultenbyK, KochanekS, et al. (2002) Pseudoachondroplasia is caused through both intra- and extracellular pathogenic pathways. J Clin Invest 110: 505–513.

62. SulemanF, GualeniB, GregsonHJ, LeightonMP, PirogKA, et al. (2012) A novel form of chondrocyte stress is triggered by a COMP mutation causing pseudoachondroplasia. Hum Mutat 33: 218–231.

63. HarewoodL, LiuM, KeelingJ, HowatsonA, WhitefordM, et al. (2010) Bilateral renal agenesis/hypoplasia/dysplasia (BRAHD): postmortem analysis of 45 cases with breakpoint mapping of two de novo translocations. PLoS One 5: e12375.

64. WilsonR, DisebergAF, GordonL, ZivkovicS, TatarczuchL, et al. (2010) Comprehensive profiling of cartilage extracellular matrix formation and maturation using sequential extraction and label-free quantitative proteomics. Mol Cell Proteomics 9: 1296–1313.

65. AsaraJM, ChristofkHR, FreimarkLM, CantleyLC (2008) A label-free quantification method by MS/MS TIC compared to SILAC and spectral counting in a proteomics screen. Proteomics 8: 994–999.